Congenital generalised lipodystrophy
Definition: A genetic disorder caused by mutations in the AGPAT2 and BSCL2 genes. It is characterized by lipoatrophy in the trunk, face, and extremities, hypertriglyceridemia, muscle hypertrophy, cardiomyopathy and hepatomegaly. Patients develop insulin resistance, leading to diabetes mellitus.
Synonyms (terms occurring on more labels are shown first): Lipodystrophy congenital
More information: PubMed search and possibly Wikipedia
Drugs with this side effect as MedDRA Preferred Term
|
License: Except as otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License. For commercial use or customized versions, please contact biobyte solutions GmbH.
Disclaimer: The content of this database of side effects (adverse drug reactions) is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.